Comment on: The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use. Reply

Rheumatology (Oxford). 2022 Feb 2;61(2):e54-e55. doi: 10.1093/rheumatology/keab769.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Arthritis, Rheumatoid* / drug therapy
  • Female
  • Humans
  • Pregnancy
  • Pregnant People
  • Sulfasalazine* / therapeutic use

Substances

  • Sulfasalazine